Approaches to studying the genomic architecture of complex birth defects.


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
08 2020
Historique:
received: 15 04 2020
revised: 18 05 2020
accepted: 23 05 2020
pubmed: 30 5 2020
medline: 3 11 2021
entrez: 30 5 2020
Statut: ppublish

Résumé

Every year nearly 6 percent of children worldwide are born with a serious congenital malformation, resulting in death or lifelong disability. In the United States, birth defects remain one of the leading causes of infant mortality. Among the common structural congenital defects are conditions known as neural tube defects (NTDs). These are a class of malformation of the brain and spinal cord where the neural tube fails to close during the neurulation. Although NTDs remain among the most pervasive and debilitating of all human developmental anomalies, there is insufficient understanding of their etiology. Previous studies have proposed that complex birth defects like NTDs are likely omnigenic, involving interconnected gene regulatory networks with associated signals throughout the genome. Advances in technologies have allowed researchers to more critically investigate regulatory gene networks in ever increasing detail, informing our understanding of the genetic basis of NTDs. Employing a systematic analysis of these complex birth defects using massively parallel DNA sequencing with stringent bioinformatic algorithms, it is possible to approach a greater level of understanding of the genomic architecture underlying NTDs. Herein, we present a brief overview of different approaches undertaken in our laboratory to dissect out the genetics of susceptibility to NTDs. This involves the use of mouse models to identify candidate genes, as well as large scale whole genome/whole exome (WGS/WES) studies to interrogate the genomic landscape of NTDs. The goal of this research is to elucidate the gene-environment interactions contributing to NTDs, thus encouraging global research efforts in their prevention.

Identifiants

pubmed: 32468575
doi: 10.1002/pd.5760
pmc: PMC8117178
mid: NIHMS1699003
doi:

Substances chimiques

Anticonvulsants 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1047-1055

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD083809
Pays : United States
Organisme : NIH HHS
ID : HD083809
Pays : United States
Organisme : NIH HHS
ID : HD081216
Pays : United States
Organisme : NICHD NIH HHS
ID : P01 HD067244
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD093758
Pays : United States
Organisme : NIEHS NIH HHS
ID : T32 ES027801
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD081216
Pays : United States
Organisme : NIH HHS
ID : HD067244
Pays : United States
Organisme : NIH HHS
ID : HD093758
Pays : United States

Informations de copyright

© 2020 John Wiley & Sons, Ltd.

Références

Hum Mutat. 2009 Jul;30(7):E706-15
pubmed: 19319979
Cell Rep. 2017 Nov 14;21(7):1795-1808
pubmed: 29141214
J Biol Chem. 2000 Nov 24;275(47):36811-7
pubmed: 10978331
Mol Psychiatry. 2008 Jun;13(6):570-84
pubmed: 18347602
Nat Commun. 2015 Mar 04;6:6388
pubmed: 25736695
Teratology. 2002 Jul;66(1):33-9
pubmed: 12115778
J Theor Biol. 2018 Apr 14;443:52-55
pubmed: 29378208
Expert Rev Neurother. 2010 Jun;10(6):943-59
pubmed: 20518610
Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):549-54
pubmed: 23267094
Hum Mutat. 2015 Mar;36(3):342-9
pubmed: 25546815
Epilepsy Res. 2002 Nov;52(1):25-33
pubmed: 12445957
Curr Drug Metab. 2009 Nov;10(9):998-1008
pubmed: 20214591
Gut. 1995 Jul;37(1):140-3
pubmed: 7672665
BMJ. 2006 Feb 4;332(7536):256
pubmed: 16455708
Hum Mol Genet. 2012 Apr 1;21(7):1496-503
pubmed: 22171071
Curr Neurol Neurosci Rep. 2011 Aug;11(4):423-7
pubmed: 21465150
Congenit Anom (Kyoto). 2017 Sep;57(5):130-133
pubmed: 28244241
Biofactors. 1988 Jul;1(2):171-6
pubmed: 2475123
Saudi Med J. 2014 Dec;35 Suppl 1:S15-28
pubmed: 25551106
Epilepsy Behav. 2006 Dec;9(4):636-40
pubmed: 17049311
Cell Res. 2018 Oct;28(10):1039-1041
pubmed: 29976953
Teratology. 1994 Feb;49(2):143-9
pubmed: 8016745
Cell Metab. 2016 Oct 11;24(4):640-641
pubmed: 27732838
Annu Rev Neurosci. 2014;37:221-42
pubmed: 25032496
Birth Defects Res A Clin Mol Teratol. 2016 Oct;106(10):847-853
pubmed: 27620832
Nat Genet. 2017 Nov;49(11):1593-1601
pubmed: 28991257
Nutrients. 2016 Nov 23;8(11):
pubmed: 27886045
Am J Med Genet A. 2017 Nov;173(11):2973-2984
pubmed: 28948692
Birth Defects Res A Clin Mol Teratol. 2013 Jun;97(6):398-402
pubmed: 23733478
Birth Defects Res A Clin Mol Teratol. 2012 Nov;94(11):875-81
pubmed: 22945317
Birth Defects Res. 2017 Jan 30;109(2):120-128
pubmed: 27883265
J Psychiatr Res. 2010 Sep;44(12):748-53
pubmed: 20185149
Annu Rev Nutr. 2010 Aug 21;30:57-81
pubmed: 20645850
J Occup Environ Med. 2002 Jul;44(7):650-6
pubmed: 12138876
Epilepsia. 2009 May;50(5):1237-46
pubmed: 19507301
Birth Defects Res A Clin Mol Teratol. 2005 Oct;73(10):679-89
pubmed: 16240378
Arch Dis Child. 1992 Dec;67(12):1442-6
pubmed: 1489222
Neurology. 2006 Aug 8;67(3):407-12
pubmed: 16894099
J Biol Chem. 2010 Feb 12;285(7):4612-20
pubmed: 19948730
Cell. 2017 Jun 15;169(7):1177-1186
pubmed: 28622505
Nat Genet. 1999 Oct;23(2):228-32
pubmed: 10508523
Hum Mol Genet. 2009 Oct 15;18(R2):R113-29
pubmed: 19808787
BMC Med Genet. 2009 Jun 03;10:49
pubmed: 19493349
BMC Public Health. 2009 Oct 16;9:391
pubmed: 19835574
Am J Hum Genet. 1999 Apr;64(4):1045-55
pubmed: 10090889
Science. 2013 Mar 1;339(6123):1222002
pubmed: 23449594
JAMA. 2001 Jun 20;285(23):2981-6
pubmed: 11410096
Rev Obstet Gynecol. 2011 Summer;4(2):52-9
pubmed: 22102928
Mol Nutr Food Res. 2006 Mar;50(3):270-4
pubmed: 16521160
Lancet Neurol. 2011 Jul;10(7):609-17
pubmed: 21652013
Birth Defects Res. 2019 Nov 1;111(18):1420-1435
pubmed: 31580536
J Med Genet. 1999 Jan;36(1):86-7
pubmed: 9950377
Mamm Genome. 2004 May;15(5):361-9
pubmed: 15170225
Ann N Y Acad Sci. 2018 Feb;1414(1):31-46
pubmed: 29363759
Genomics. 1999 Sep 15;60(3):295-308
pubmed: 10493829
J Biol Chem. 2001 Sep 21;276(38):35961-6
pubmed: 11470804
Hypertension. 2003 May;41(5):1041-6
pubmed: 12654705
J Hypertens. 2004 Oct;22(10):1903-7
pubmed: 15361761
Birth Defects Res A Clin Mol Teratol. 2013 Jun;97(6):403-8
pubmed: 23733498
Paediatr Perinat Epidemiol. 2012 Nov;26(6):578-88
pubmed: 23061694
Nat Rev Neurosci. 2006 Sep;7(9):724-31
pubmed: 16924261
Biochem Pharmacol. 1992 Jun 9;43(11):2435-42
pubmed: 1610408
Br J Nutr. 2009 Jul;102(2):173-80
pubmed: 19079944
J Biol Chem. 2004 Aug 6;279(32):33829-36
pubmed: 15140890
Nat Genet. 2010 Jul;42(7):565-9
pubmed: 20562875
Birth Defects Res A Clin Mol Teratol. 2003 Jun;67(6):409-13
pubmed: 12962284
Am J Public Health. 1998 Nov;88(11):1674-80
pubmed: 9807535
Proc Natl Acad Sci U S A. 2018 May 1;115(18):4690-4695
pubmed: 29666258

Auteurs

Toluwani E Taiwo (TE)

Rice University, Houston, Texas, USA.
Center for Precision Environmental Health, Baylor College of Medicine, Houston, Texas, USA.

Xuanye Cao (X)

Center for Precision Environmental Health, Baylor College of Medicine, Houston, Texas, USA.
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.

Robert M Cabrera (RM)

Center for Precision Environmental Health, Baylor College of Medicine, Houston, Texas, USA.
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.

Yunping Lei (Y)

Center for Precision Environmental Health, Baylor College of Medicine, Houston, Texas, USA.
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.

Richard H Finnell (RH)

Center for Precision Environmental Health, Baylor College of Medicine, Houston, Texas, USA.
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.
Departments of Molecular and Human Genetics and Medicine, Baylor College of Medicine, Houston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH